(Q39173834)

9 September 2017

title

Immunotoxin targeting CD133(+) breast carcinoma cells (English)

1 reference

9 September 2017

1 reference

8

Daniel A Vallera

1 reference

9 September 2017

John R Ohlfest

1

1 reference

9 September 2017

David M Zellmer

2

1 reference

9 September 2017

Jayanth Panyam

3

1 reference

9 September 2017

Suresh Kumar Swaminathan

4

1 reference

9 September 2017

Seunguk Oh

5

1 reference

9 September 2017

Nate N Waldron

6

1 reference

9 September 2017

Shoko Toma

7

1 reference

9 September 2017

publication date

1 April 2013

1 reference

Drug delivery and translational research

9 September 2017

published in

1 reference

9 September 2017

volume

3

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

195-204

1 reference

https://scigraph.springernature.com/pub.10.1007/s13346-012-0066-2

9 September 2017

exact match

0 references

cites work

Self-renewal and solid tumor stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Cancer stem cells: a step toward the cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Therapeutic implications of colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Identification of a novel monoclonal antibody recognizing CD133

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Immunotoxin treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Targeted toxin therapy for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Establishment of epithelial cell line MDA-MB-157 from metastatic pleural effusion of human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0066-2

Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients

21 January 2018

1 reference

12 December 2020

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors

1 reference

12 December 2020

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

12 December 2020

AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family?

1 reference

12 December 2020

Ultrastructural characterization of CD133+stem cells bound to superparamagnetic nanoparticles: possible biotechnological applications

1 reference

12 December 2020

Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas

1 reference

12 December 2020

Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses

1 reference

12 December 2020

AC133, a novel marker for human hematopoietic stem and progenitor cells

1 reference

12 December 2020

Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor

1 reference

12 December 2020

10.1007/S13346-012-0066-2

Identifiers

DOI

1 reference

9 September 2017

1 reference